TrialThe Prostate2015

Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.

Christopher M Heaphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.